Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'muscarinic agonist' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 80 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Saitoh, H; Masuda, T; Shimura, S; Fushimi, T; Shirato, K
      Secretion and gene expression of secretory leukocyte protease inhibitor byhuman airway submucosal glands

      AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY
    2. Jung, MH; Park, JG; Yang, KJ; Lee, MJ
      Synthesis and muscarinic activity of 1,2,3,4-tetrahydropyrimidine derivatives

      ARCHIV DER PHARMAZIE
    3. Ikonen, S; Tanila, H
      Effects of metrifonate on the hippocampal theta rhythm of freely moving intact and MS-lesioned mice

      PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR
    4. Wienrich, M; Meier, D; Ensinger, HA; Gaida, W; Raschig, A; Walland, A; Hammer, R
      Pharmacodynamic profile of the M-1 agonist talsaclidine in animals and man

      LIFE SCIENCES
    5. Park, K; Evans, RL; Watson, GE; Nehrke, K; Richardson, L; Bell, SM; Schultheis, PJ; Hand, AR; Shull, GE; Melvin, JE
      Defective fluid secretion and NaCl absorption in the parotid glands of Na+/H+ exchanger-deficient mice

      JOURNAL OF BIOLOGICAL CHEMISTRY
    6. Grutzendler, J; Morris, JC
      Cholinesterase inhibitors for Alzheimer's disease

      DRUGS
    7. Imai, Y; Jiang, B; Pappano, AJ
      Mechanism for muscarinic inhibition of I-Ca(L) is determined by the path for elevating cyclic AMP in cardiac myocytes

      CARDIOVASCULAR RESEARCH
    8. Bymaster, FP; Carter, PA; DeLapp, NW; Calligaro, DO; Felder, CC
      Receptor reserve of phosphoinositide-coupled muscarinic receptors in mousehippocampus in vivo

      BRAIN RESEARCH
    9. Xu, Z; Ross, MG; Johnson, AK
      Intracerebroventricular carbachol induces FOS immunoreactivity in lamina terminalis neurons projecting to the supraoptic nucleus

      BRAIN RESEARCH
    10. Perry, KW; Nisenbaum, LK; George, CA; Shannon, HE; Felder, CC; Bymaster, FP
      The muscarinic agonist xanomeline increases monoamine release and immediate early gene expression in the rat prefrontal cortex

      BIOLOGICAL PSYCHIATRY
    11. Plate, R; Plaum, MJM; Van der Hulst, RGA; de Boer, T
      Synthesis and in vitro muscarinic activities of a series of 3-(pyrazol-3-yl)-1-azabicyclo[2.2.2]octanes

      BIOORGANIC & MEDICINAL CHEMISTRY
    12. Makita, T; Horie, M; Xie, LH; Okada, Y; Sasayama, S
      Agonist-independent modulation of L-type Ca currents by basal G(s) proteinactivities in single guinea pig ventricular myocytes

      HEART AND VESSELS
    13. O'Neill, J; Halgren, E; Marinkovic, K; Siembieda, D; Refai, D; Fitten, LJ; Perryman, K; Fisher, A
      Effects of muscarinic and adrenergic agonism on auditory P300 in the macaque

      PHYSIOLOGY & BEHAVIOR
    14. Thal, LJ; Forrest, M; Loft, H; Mengel, H
      Lu 25-109, a muscarinic agonist, fails to improve cognition in Alzheimer'sdisease

      NEUROLOGY
    15. Bartolomeo, AC; Morris, H; Buccafusco, JJ; Kille, N; Rosenzweig-Lipson, S; Husbands, MG; Sabb, AL; Abou-Gharbia, M; Moyer, JA; Boast, CA
      The preclinical pharmacological profile of WAY-132983, a potent M1 preferring agonist

      JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
    16. Iwata, N; Kozuka, M; Hara, T; Kaneko, T; Tonohiro, T; Sugimoto, M; Nittsu, Y; Kondo, Y; Yamamoto, T; Sakai, J; Nagano, M
      Activation of cerebral function by CS-932, a functionally selective M-1 partial agonist: Neurochemical characterization and pharmacological studies

      JAPANESE JOURNAL OF PHARMACOLOGY
    17. Fisher, A
      Therapeutic strategies in Alzheimer's disease: M1 muscarinic agonists

      JAPANESE JOURNAL OF PHARMACOLOGY
    18. Rasmussen, T; Sauerberg, P; Nielsen, EB; Swedberg, MDB; Thomsen, C; Sheardown, MJ; Jeppesen, L; Calligaro, DO; DeLapp, NW; Whitesitt, C; Ward, JS; Shannon, HE; Bymaster, FP; Fink-Jensen, A
      Muscarinic receptor agonists decrease cocaine self-administration rates indrug-naive mice

      EUROPEAN JOURNAL OF PHARMACOLOGY
    19. Bymaster, FP; Calligaro, DO; Falcone, JF
      Arachidonic acid release in cell tines transfected with muscarinic receptors: A simple functional assay to determine response of agonists

      CELLULAR SIGNALLING
    20. Martinez, A; Alonso, D; Castro, A; Aran, VJ; Cardelus, I; Banos, JE; Badia, A
      Synthesis and potential muscarinic receptor binding and antioxidant properties of 3-(thiadiazolyl)pyridine 1-oxide compounds

      ARCHIV DER PHARMAZIE
    21. Ruske, AC; White, KG
      Facilitation of memory performance by a novel muscarinic agonist in young and old rats

      PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR
    22. Bymaster, FP; Shannon, HE; Rasmussen, K; DeLapp, NW; Ward, JS; Calligaro, DO; Mitch, CH; Whitesitt, C; Ludvigsen, TS; Sheardown, M; Swedberg, M; Rasmussen, T; Olesen, PH; Jeppesen, L; Sauerberg, P; Fink-Jensen, A
      Potential role of muscarinic receptors in schizophrenia

      LIFE SCIENCES
    23. Genis, I; Fisher, A; Michaelson, DM
      Site-specific dephosphorylation of tau of apolipoprotein E-deficient and control mice by M1 muscarinic agonist treatment

      JOURNAL OF NEUROCHEMISTRY
    24. PLATE R; PLAUM MJM; PINTAR P; JANS CG; DEBOER T; DIJCKS FA; RUIGT G; ANDREWS JS
      SYNTHESIS, AND IN-VITRO AND IN-VIVO MUSCARINIC PHARMACOLOGICAL PROPERTIES OF A SERIES OF 1,6-DIHYDRO-5-(4H)-PYRIMIDINONE OXIMES

      Bioorganic & medicinal chemistry
    25. PETRY NM; BICKEL WK; HUDDLESTON J; TZANIS E; BADGER GJ
      A COMPARISON OF SUBJECTIVE, PSYCHOMOTOR AND PHYSIOLOGICAL-EFFECTS OF A NOVEL MUSCARINIC ANALGESIC, LY297802 TARTRATE, AND ORAL MORPHINE IN OCCASIONAL DRUG-USERS

      Drug and alcohol dependence
    26. LIBRI V; CONSTANTI A; POSTLETHWAITE M; BOWERY NG
      BLOCKADE OF GABA(B) RECEPTORS FACILITATES MUSCARINIC AGONIST-INDUCED EPILEPTIFORM ACTIVITY IN IMMATURE RAT PIRIFORM CORTEX IN-VITRO

      Naunyn-Schmiedeberg's archives of pharmacology
    27. Iga, Y; Arisawa, H; Ogane, N; Saito, Y; Tomizuka, T; Nakagawa-Yagi, Y; Masunaga, H; Yasuda, H; Miyata, N
      (+/-)-cis-2-methylspiro[1,3-oxathiolane-5,3 '-quinuclidine]hydrochloride, hemihydrate (SNI-2011, cevimeline hydrochloride) induces saliva and tear secretions in rats and mice: The role of muscarinic acetylcholine receptors

      JAPANESE JOURNAL OF PHARMACOLOGY
    28. LESTAGE P; IRISHUGOT A; GANDON MH; LEPAGNOL J
      INVOLVEMENT OF NICOTINERGIC MECHANISMS IN THYROTROPIN-RELEASING HORMONE-INDUCED NEUROLOGIC RECOVERY AFTER CONCUSSIVE HEAD-INJURY IN THE MOUSE

      European journal of pharmacology
    29. Watson, J; Brough, S; Coldwell, MC; Gager, T; Ho, M; Hunter, AJ; Jerman, J; Middlemiss, DN; Riley, GJ; Brown, AM
      Functional effects of the muscarinic receptor agonist, xanomeline, at 5-HT1 and 5-HT2 receptors

      BRITISH JOURNAL OF PHARMACOLOGY
    30. BYMASTER FP; CARTER PA; PETERS SC; ZHANG W; WARD JS; MITCH CH; CALLIGARO DO; WHITESITT CA; DELAPP N; SHANNON HE; RIMVALL K; JEPPESEN L; SHEARDOWN MJ; FINKJENSEN A; SAUERBERG P
      XANOMELINE COMPARED TO OTHER MUSCARINIC AGENTS ON STIMULATION OF PHOSPHOINOSITIDE HYDROLYSIS IN-VIVO AND OTHER CHOLINOMIMETIC EFFECTS

      Brain research
    31. SATITPUNWAYCHA P; RIVERS RJ
      VOLATILE ANESTHETIC AGENTS AND VASCULAR COMMUNICATION IN THE MICROCIRCULATION OF THE HAMSTER-CHEEK POUCH

      Anesthesiology
    32. MARTINOTTI E; CALDERONE V; BRESCHI MC; BANDINI P; CIONI PL
      PHARMACOLOGICAL ACTION OF AQUEOUS CRUDE EXTRACTS OF ARTEMISIA-VERLOTORUM LAMOTTE (COMPOSITAE)

      PTR. Phytotherapy research
    33. SAEKI T; SHEN JB; PAPPANO AJ
      CARBACHOL PROMOTES NA+ ENTRY AND AUGMENTS NA CA EXCHANGE CURRENT IN GUINEA-PIG VENTRICULAR MYOCYTES/

      American journal of physiology. Heart and circulatory physiology
    34. RIVERS RJ
      CUMULATIVE CONDUCTED VASODILATION WITHIN A SINGLE ARTERIOLE AND THE MAXIMUM CONDUCTED RESPONSE

      American journal of physiology. Heart and circulatory physiology
    35. ENSINGER HA; BECHTEL WD; BIRKE FW; MENDLA KD; MIERAU J; SPECK G; TROGER W
      WAL-2014-FU (TALSACLIDINE) - A PREFERENTIALLY NEURON ACTIVATING MUSCARINIC AGONIST FOR THE TREATMENT OF ALZHEIMERS-DISEASE

      Drug development research
    36. BYMASTER FP; WHITESITT CA; SHANNON HE; DELAPP N; WARD JS; CALLIGARO DO; SHIPLEY LA; BUELKESAM JL; BODICK NC; FARDE L; SHEARDOWN MJ; OLESEN PH; HANSEN KT; SUZDAK PD; SWEDBERG MDB; SAUERBERG P; MITCH CH
      XANOMELINE - A SELECTIVE MUSCARINIC AGONIST FOR THE TREATMENT OF ALZHEIMERS-DISEASE

      Drug development research
    37. SRAMEK JJ; FORREST M; MENGEL H; JHEE SS; HOURANI J; CUTLER NR
      A BRIDGING STUDY OF LU-25-109 IN PATIENTS WITH PROBABLE ALZHEIMERS-DISEASE

      Life sciences
    38. WALLAND A; BURKARD S; HAMMER R; TROGER W
      IN-VIVO CONSEQUENCES OF M(1)-RECEPTOR ACTIVATION BY TALSACLIDINE

      Life sciences
    39. LANZAFAME A; CHRISTOPOULOS A; MITCHELSON F
      INTERACTIONS OF AGONISTS WITH AN ALLOSTERIC ANTAGONIST AT MUSCARINIC ACETYLCHOLINE M(2)-RECEPTORS (VOL 316, PG 27, 1996)

      European journal of pharmacology
    40. MACDONELL KL; DIAMOND J
      CYCLIC GMP-DEPENDENT PROTEIN-KINASE ACTIVATION IN THE ABSENCE OF NEGATIVE INOTROPIC EFFECTS IN THE RAT VENTRICLE

      British Journal of Pharmacology
    41. HARTVIG P; TORSTENSON R; BJURLING P; FASTH KJ; LANGSTROM B; NORDBERG A
      REGIONAL BRAIN DISTRIBUTION AND BINDING OF THE MUSCARINIC RECEPTOR AGONIST CI-979 STUDIED BY POSITRON EMISSION TOMOGRAPHY IN THE MONKEY

      Dementia and geriatric cognitive disorders
    42. BALL DC; HICKS JW
      ADRENERGIC AND CHOLINERGIC RESPONSE OF VENTRICULAR MUSCLE FROM THE TURTLE, TRACHEMYS (PSEUDEMYS) SCRIPTA

      Comparative biochemistry and physiology. Part A, Physiology
    43. MARTIN JR
      PRESSOR EFFECT OF THE PUTATIVE M(1) MUSCARINIC RECEPTOR AGONIST MCN-A-343 IN THE CONSCIOUS RAT

      Life sciences
    44. LANZAFAME A; CHRISTOPOULOS A; MITCHELSON F
      INTERACTIONS OF AGONISTS WITH AN ALLOSTERIC ANTAGONIST AT MUSCARINIC ACETYLCHOLINE M(2) RECEPTORS

      European journal of pharmacology
    45. DRIJFHOUT WJ; GROL CJ; WESTERINK BHC
      PARASYMPATHETIC INHIBITION OF PINEAL INDOLE METABOLISM BY PREJUNCTIONAL MODULATION OF NORADRENALINE RELEASE

      European journal of pharmacology
    46. IGA Y; ARISAWA H; ISE M; YASUDA H; TAKESHITA Y
      MODULATION OF RHYTHMICAL SLOW ACTIVITY, LONG-TERM POTENTIATION AND MEMORY BY MUSCARINIC RECEPTOR AGONISTS

      European journal of pharmacology
    47. FOUCART S; GIBBONS SJ; BRORSON JR; MILLER RJ
      INCREASES IN [CA2-RAT SYMPATHETIC NEURONS ARE NOT DEPENDENT ON INTRACELLULAR CA2+ POOLS(](I) BY CCH IN ADULT)

      American journal of physiology. Cell physiology
    48. GUERINEAU NC; BOSSU JL; GAHWILER BH; GERBER U
      ACTIVATION OF A NONSELECTIVE CATIONIC CONDUCTANCE BY METABOTROPIC GLUTAMATERGIC AND MUSCARINIC AGONISTS IN CA3 PYRAMIDAL NEURONS OF THE RATHIPPOCAMPUS

      The Journal of neuroscience
    49. ALLEN NHP; BURNS A
      THE TREATMENT OF ALZHEIMERS-DISEASE

      JOURNAL OF PSYCHOPHARMACOLOGY
    50. LENZ SM; MEIER E; PEDERSEN H; FREDERIKSEN K; BOGESO KP; KROGSGAARDLARSEN P
      MUSCARINIC AGONISTS - SYNTHESES AND STRUCTURE-ACTIVITY-RELATIONSHIPS OF BICYCLIC ISOXAZOLE ESTER BIOISOSTERES OF NORARECOLINE

      European journal of medicinal chemistry
    51. SRAMEK JJ; SEDMAN AJ; REECE PA; HOURANI J; BOCKBRADER H; CUTLER NR
      SAFETY AND TOLERABILITY OF CI-979 IN PATIENTS WITH ALZHEIMERS-DISEASE

      Life sciences
    52. ECKOLS K; BYMASTER FP; MITCH CH; SHANNON HE; WARD JS; DELAPP NW
      THE MUSCARINIC M1 AGONIST XANOMELINE INCREASES SOLUBLE AMYLOID PRECURSOR PROTEIN RELEASE FROM CHINESE-HAMSTER OVARY-M1 CELLS

      Life sciences
    53. SEDMAN AJ; BOCKBRADER H; SCHWARZ RD
      PRECLINICAL AND PHASE-1 CLINICAL CHARACTERIZATION OF CI-979 RU35926, A NOVEL MUSCARINIC AGONIST FOR THE TREATMENT OF ALZHEIMERS-DISEASE/

      Life sciences
    54. ADAMUS WS; LEONARD JP; TROGER W
      PHASE-I CLINICAL-TRIALS WITH WAL-2014, A NEW MUSCARINIC AGONIST FOR THE TREATMENT OF ALZHEIMERS-DISEASE

      Life sciences
    55. BORDIN S; BOSCHERO AC; CARNEIRO EM; ATWATER I
      IONIC MECHANISMS INVOLVED IN THE REGULATION OF INSULIN-SECRETION BY MUSCARINIC AGONISTS

      The Journal of membrane biology
    56. TSUKAMOTO S; NAGAOKA H; IGARASHI S; WANIBUCHI F; HIDAKA K; TAMURA T
      SYNTHESIS AND STRUCTURE-ACTIVITY STUDIES OF A SERIES OF 1-OXA-2,8-DIAZASPIRO[4.5]DECAN-3-ONES AND RELATED-COMPOUNDS AS M(1) MUSCARINIC AGONISTS

      Chemical and Pharmaceutical Bulletin
    57. TSUKAMOTO S; FUJII M; YASUNAGA T; MATSUDA K; WANIBUCHI F; HIDAKA K; FURUYA T; TAMURA T
      SYNTHESIS AND STRUCTURE-ACTIVITY STUDIES OF A SERIES OF 1-OXA-8-AZASPIRO[4.5]DECANES AS M(1) MUSCARINIC AGONISTS

      Chemical and Pharmaceutical Bulletin
    58. CARRIER GO
      WHOLE-CELL AND PERFORATED-PATCH RECORDINGS OF 4 DISTINCT K-SUPERIOR MESENTERIC GANGLIA NEURONS OF ADULT-RATS( CURRENTS IN ACUTELY DISPERSEDCELIAC)

      Brain research
    59. YAMAGUCHI T; SUZUKI M; YAMAMOTO M
      YM796, A NOVEL MUSCARINIC AGONIST, IMPROVES THE IMPAIRMENT OF LEARNING-BEHAVIOR IN A RAT MODEL OF CHRONIC FOCAL CEREBRAL-ISCHEMIA

      Brain research
    60. DAVID JA; PITMAN RM
      MUSCARINIC AGONISTS MODULATE CALCIUM-DEPENDENT OUTWARD CURRENTS IN ANIDENTIFIED INSECT MOTONEURON

      Brain research
    61. RODRIGUEZ RJ; DRESHAJ IA; KUMAR G; MILLER MJ; MARTIN RJ
      MATURATION OF THE CHOLINERGIC RESPONSE OF TRACHEAL SMOOTH-MUSCLE IN THE PIGLET

      Pediatric pulmonology
    62. MOHR E; MENDIS T; RUSK IN; GRIMES JD
      NEUROTRANSMITTER REPLACEMENT THERAPY IN ALZHEIMERS-DISEASE

      Journal of psychiatry & neuroscience
    63. MALTBY N; BROE GA; CREASEY H; JORM AF; CHRISTENSEN H; BROOKS WS
      EFFICACY OF TACRINE AND LECITHIN IN MILD-TO-MODERATE ALZHEIMERS-DISEASE - DOUBLE-BLIND TRIAL

      BMJ. British medical journal
    64. SOARES JC; GERSHON S
      ADVANCES IN THE PHARMACOTHERAPY OF ALZHEIMERS-DISEASE

      European archives of psychiatry and clinical neuroscience
    65. METIOUI M; GROSFILS K; DEHAYE JP
      REGULATION BY THAPSIGARGIN AND CARBACHOL OF THE INTRACELLULAR CALCIUM-CONCENTRATION IN RAT SUBMANDIBULAR GLANDS

      General pharmacology
    66. OLIVEIRA MA; PRADO WA
      ANTINOCICEPTION AND BEHAVIORAL MANIFESTATIONS INDUCED BY INTRACEREBROVENTRICULAR OR INTRA-AMYGDALOID ADMINISTRATION OF CHOLINERGIC AGONISTSIN THE RAT

      Pain
    67. BAI DL; SATTELLE DB
      MUSCARINIC ACETYLCHOLINE-RECEPTORS ON AN IDENTIFIED MOTOR-NEURON IN THE COCKROACH, PERIPLANETA-AMERICANA

      Neuroscience letters
    68. CIGNARELLA G; VILLA S; CATTABENI F; RENO F; CIMINO M; DEBENEDETTI PG; BARLOCCO D
      SYNTHESIS OF A NEW SERIES OF 2,8-DISUBSTITUTED-2,8-DIAZASPIRO[4,5]DECAN-1-ONES AS POTENTIAL MUSCARINIC AGONISTS

      European journal of medicinal chemistry
    69. MATSUMOTO S; YORIO T; DESANTIS L; PANG IH
      MUSCARINIC EFFECTS ON CELLULAR FUNCTIONS IN CULTURED HUMAN CILIARY MUSCLE-CELLS

      Investigative ophthalmology & visual science
    70. SCHNEIDER LS; TARIOT PN
      EMERGING DRUGS FOR ALZHEIMERS-DISEASE - MECHANISMS OF ACTION AND PROSPECTS FOR COGNITIVE ENHANCING MEDICATIONS

      The Medical clinics of North America
    71. HONDA K; TAKANO Y; KAMIYA H
      THE MECHANISM OF MUSCARINIC AGONIST-STIMULATED INOSITOL PHOSPHATE FORMATION IN PERMEABILIZED ILEAL SMOOTH-MUSCLE

      Japanese Journal of Pharmacology
    72. KHARE S; TIEN XY; WILSON D; WALI RK; BISSONNETTE BM; SITRIN MD; BRASITUS TA
      VITAMIN-D STATUS MODULATES RAT COLONIC M(3)-MUSCARINIC RECEPTOR CHARACTERISTICS AND COUPLING TO GUANYLATE-CYCLASE

      FEBS letters
    73. WANIBUCHI F; NISHIDA T; YAMASHITA H; HIDAKA K; KOSHIYA K; TSUKAMOTO S; USUDA S
      CHARACTERIZATION OF A NOVEL MUSCARINIC RECEPTOR AGONIST, YM796 - COMPARISON WITH CHOLINESTERASE-INHIBITORS IN IN-VIVO PHARMACOLOGICAL STUDIES

      European journal of pharmacology
    74. PATEL S; HUTSON PH
      HYPOTHERMIA INDUCED BY CHOLINOMIMETIC DRUGS IS BLOCKED BY GALANIN - POSSIBLE INVOLVEMENT OF ATP-SENSITIVE K+ CHANNELS

      European journal of pharmacology
    75. HOHAGEN F; RIEMANN D; SPIEGEL R; HOLZHAUER M; BERGER M
      INFLUENCE OF THE CHOLINERGIC AGONIST SDZ-210-086 ON SLEEP IN HEALTHY-SUBJECTS

      Neuropsychopharmacology
    76. PATHY MSJ
      THE PHARMACOLOGICAL MANAGEMENT OF COGNITIVE IMPAIRMENT IN THE DEMENTED PATIENT

      Progress in neuro-psychopharmacology & biological psychiatry
    77. AOKI T; NAKANE T; CHIBA S
      ACETYLCHOLINE-INDUCED VASOCONSTRICTIONS VIA MUSCARINIC M(3) RECEPTORSON SMOOTH-MUSCLE OF CANINE BASILAR ARTERIES

      Asia Pacific journal of pharmacology
    78. DAWSON GR; IVERSEN SD
      THE EFFECTS OF NOVEL CHOLINESTERASE-INHIBITORS AND SELECTIVE MUSCARINIC RECEPTOR AGONISTS IN TESTS OF REFERENCE AND WORKING-MEMORY

      Behavioural brain research
    79. SOEJIMA O; KATSURAGI T; FURUKAWA T
      OPPOSITE MODULATION BY MUSCARINIC-M(1) AND MUSCARINIC-M(3) RECEPTORS OF ACETYLCHOLINE-RELEASE FROM GUINEA-PIG ILEUM AS MEASURED DIRECTLY

      European journal of pharmacology
    80. SORIMACHI M
      CAFFEINE AND MUSCARINIC RECEPTOR AGONIST-SENSITIVE CA2-CELLS( STORES IN CHICK CILIARY GANGLION)

      Brain research


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 19/02/20 alle ore 21:50:14